Charles River Laboratories | CRL - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
169.80
Cambio Giornaliero
2.06 1.23%
Mensile
2.36%
Annuale
48.09%
Q2 Previsione
166.17




Spese Di Vendita E Di Amministrazione Cambiamento Data
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Bruker USD 247.2M 4.7M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cigna USD 3.19B 242M 2025-09
Concord Medical Services Hldg CNY 140.37M 36.24M 2025-06
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Elevance Health USD 10.91B 309M 2025-12
Galapagos EUR 44.42M 9.87M 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 283M 27M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Intrexon USD 10.31M 41K 2024-06
IQVIA Holdings USD 468M 46M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
McKesson USD 2.03B 44M 2025-12
Merck EUR 1.6B 136M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Revvity USD 251.73M 9.82M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
United Therapeutics USD 190.6M 38.6M 2025-12
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 240.01M 25.78M 2025-12
West Pharmaceutical Services USD 99.5M 7M 2026-03